Grufity logo
Grufity logo
TELA

TELA - Tela Bio Inc Stock Price, Fair Value and News

$0.89-0.02 (-2.20%)
Market Closed as of 10 Sep 2026, 04:00 pm ET

65/100

TELA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

65/100

TELA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

TELA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TELA Price Action

Last 7 days

14.1%

Last 30 days

12.7%

Last 90 days

3.5%

Trailing 12 Months

-43.3%

TELA RSI Chart

TELA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TELA Valuation

Market Cap

40.0M

Price/Earnings (Trailing)

-0.97

Price/Sales (Trailing)

0.5

EV/EBITDA

-0.28

Price/Free Cashflow

-1.26

TELA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

TELA Fundamentals

TELA Revenue

Revenue (TTM)

79.9M

Rev. Growth (Yr)

-4.49%

Rev. Growth (Qtr)

1.22%

TELA Earnings

Earnings (TTM)

-41.2M

Earnings Growth (Yr)

-13.49%

Earnings Growth (Qtr)

8.24%

TELA Profitability

EBT Margin

-51.20%

Return on Equity

259.54%

Return on Assets

-68.93%

Free Cashflow Yield

-79.14%

TELA Investor Care

Shares Dilution (1Y)

13.42%

Diluted EPS (TTM)

-0.77

TELA Alerts

  • 1 major insider buys recently.
Revenue & Growth

How Tela Bio Inc generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
202680.8M79.9M--
202571.2M75.3M77.1M80.3M
202463.1M64.7M68.6M69.3M
202345.1M49.2M53.1M58.5M
202231.8M34.7M38.2M41.4M
202120.4M24.4M26.8M29.5M
202015.9M16.1M17.4M18.2M
201910.1M11.9M13.7M15.4M
2018--6.3M8.3M
2017---4.2M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Tela Bio Inc

TELA
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
 CEO
 WEBSITEtelabio.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES173

Tela Bio Inc Frequently Asked Questions

TELA is the stock ticker symbol of Tela Bio Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu Sep 10 2026, market cap of Tela Bio Inc is 39.96 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Thu Sep 10 2026, TELA's PE ratio (Price to Earnings) is -0.97 and Price to Sales (PS) ratio is 0.5. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TELA PE ratio will change depending on the future growth rate expectations of investors.